Applying Data to Practice

Program Goals

Clinical Recommendations for Basal Insulin Therapy in Type 2 Diabetes

Metformin Plus Liraglutide Followed by Add-on of Detemir

Insulin Glargine 300 U/mL (U-300) Similar Efficacy and Lower Nocturnal Hypoglycemia Rates vs U-100

Insulin Degludec PK/PD Profile Stable, Ultra-long Acting Basal Activity

Insulin Degludec “Flexible” Treatment Regimen

Investigational Basal Insulin Peglispro (BIL)*

Physiology of Insulin BIL* Hypothesis

IDegLira* Is Superior to Glargine in HbA1c Reduction

Where Do Coformulation GLP-1 Agonist/Basal Insulin Fit?

Insulin Glargine U-300 Dosing

Titrating Ultra-Long Acting Basal Insulins

Reasons for Delaying Initiation of Basal Insulin

Clinical Caveats With Next-Generation Basal Insulin Analogs

Closing Comments

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)